SMEs and start-ups should be provided with the best conditions to make their innovations economically viable. This is the incentive for a collaboration between the Swiss Federal Institute of Intellectual Property (IPI) and Innosuisse, the Swiss Innovation Agency.
Today, the key to economic success is a combination of knowledge, experience, research and development. By offering targeted support, Innosuisse is helping to promote science-based innovations in Switzerland, create jobs with high added value and boost prosperity. Innosuisse’s funding activities primarily involve supporting innovation projects jointly run by companies and research institutions.
Innosuisse provides start-ups and those looking to set up a company with experienced coaches who offer guidance on establishing, developing and growing a company.
Raising awareness of intellectual property
Intellectual property plays a crucial role in the innovation process. As part of its collaboration, the IPI therefore encourages companies to consider protecting their innovation from an early stage. Anyone who puts into practice an ingenious idea should be able to protect their invention from being copied. This forms the basis for companies to capitalise on their inventions.
The Assisted Patent Search is at the heart of the collaboration between Innosuisse and the IPI. Those who apply for funding from Innosuisse can take advantage of a free, one-off search carried out at the IPI, as well as an additional Patent Landscape Analysis if needed. This service allows companies to put their idea or invention under the microscope and find out if it is new and how they may want to proceed.
Greater efficiency in the fight against counterfeiting
The motion “Towards a modern Swiss patent” has been approved – the IPI is preparing a preliminary draft of the revision of the Patents Act
29.11.2019 | Media release
Corina Eichenberger-Walther to take over the presidency of the Institute Council of the IPI
08.11.2019 | Event
Symposium on Creative Approaches to Improving Access to Medicines Globally
Roundtable on the protection of computer-implemented inventions